Placenta-Derived Mesenchymal Stem Cells Reduce the Interleukin-5 Level Experimentally in Children with Asthma

Background: Mesenchymal stem cells (MSCs) have been investigated as a new treatment option for various diseases in recent years. However, the role of placenta-derived MSCs in children with asthma remains unclear. We assessed the effect of placenta-derived MSCs on T cell immune responses and cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Sheng-Chieh, Liou, Yih-Mei, Ling, Thai-Yen, Chuang, Ya-Hui, Chiang, Bor-Luen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818200/
https://www.ncbi.nlm.nih.gov/pubmed/31673233
http://dx.doi.org/10.7150/ijms.33590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818200/
https://www.ncbi.nlm.nih.gov/pubmed/31673233
http://dx.doi.org/10.7150/ijms.33590

Ejemplares similares